Karen M. Miner - Concepedia

Author

Karen M. Miner

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

K M Miner, K. M. Miner, KAREN M. MINER, Karen M. Miner, Miner, Karen M.

Publications

503

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)The University of Texas System

About

Karen M. Miner is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	492
2	Health Sciences	2	2	89
3	Natural Sciences	1	1	53
4	Allergy	1	1	43
5	Biochemistry	1	1	53

Karen M. Miner

Publications

492

Citations

H-Index

Page 1

	Year	Citations
Clonal drift of cell surface, melanogenic, and experimental metastatic properties of in vivo-selected, brain meninges-colonizing murine B16 melanoma. Karen M. Miner, Takanori Kawaguchi, Grant W. Uba, PubMed Experimental Metastatic PropertiesTissue Culture GrowthMelanomaClonal DriftBrain Tumor Colonies	1982	125
Differences in the sensitivities of murine metastatic lymphoma/lymphosarcoma variants to macrophage-mediated cytolysis and/or cytostasis. Karen M. Miner, Garth L. Nicolson PubMed Parental Raw117Lymphoid NeoplasiaLarge Cell LymphomaSequential SelectionMalignant Disease	1983	66
Characterization of murine monoclonal antibodies to Escherichia coli J5 Karen M. Miner, C L Manyak, Emily L. Williams, Infection and Immunity J5 EndotoxinMedicineVirulence FactorPathogenesisImmunology	1986	63
Sodium-Stimulated Glutamate Transport in Osmotically Shocked Cells and Membrane Vesicles of <i>Escherichia coli</i> Karen M. Miner, Leonard Frank Journal of Bacteriology Distinct StrainsBacteriologyMolecular BiologyBacterial PathogensCellular Physiology	1974	53
Subfractionation of malignant variants of metastatic murine lymphosarcoma cells by countercurrent distribution in two-polymer aqueous phases Karen M. Miner, Harry Walter, Garth L. Nicolson Biochemistry Altmetric Attention ScorePathologyTumor BiologyOncologyTwo-polymer Aqueous Phases	1981	46
Human monoclonal antibodies that protect mice against challenge with Pseudomonas aeruginosa Hans J. Zweerink, Maureen C. Gammon, Cameron F. Hutchison, Infection and Immunity Laboratory ImmunologyHumoral ResponseImmunologyAntigen ProcessingHuman Monoclonal Antibodies	1988	43
In vivo and in vitro properties of malignant variants of RAW117 metastatic murine lymphoma/lymphosarcoma Christopher L. Reading, Paul M. Kraemer, Karen M. Miner, Clinical & Experimental Metastasis Tumor BiologyLymphoid NeoplasiaMalignant DiseaseTumor HeterogeneityMedicine	1983	36
Differences in Cytotoxic Effects of Activated Murine Peritoneal Macrophages and J774 Monocytic Cells on Metastatic Variants of B16 Melanoma<xref ref-type="fn" rid="fn2">2</xref><xref ref-type="fn" rid="fn3">3</xref> Karen M. Miner, Jim Klostergaard, Gale A. Granger, JNCI Journal of the National Cancer Institute Immune RegulationImmunologyPathologyImmune SystemTumor Biology	1983	32
Brain meninges tumor formation byin vivo-selected metastatic B16 melanoma variants in mice Takanori Kawaguchi, Michiko Kawaguchi, Karen M. Miner, Clinical & Experimental Metastasis MelanomaBrain MeningesPathologyMedicineCell Biology	1983	28

Page 1